image
Immunovant, Inc. IMVT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 26.63
-5.06 %
$ 3.91 B
Market Cap
-12.05
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2024-03-31 0.00% -22.93% -42.44%
Annual Report FY 10-K 2023-03-31 0.00% -34.60% -27.09%
Annual Report FY 10-K 2022-03-31 0.00% -45.89% -44.87%
Annual Report FY 10-K 2021-03-31 0.00% -61.82% -64.15%
Annual Report FY 10-K 2020-03-31 0.00% -14818650.00% -14592344.44%
Annual Report FY 10-K 2019-03-31 0.00% 100.00% 100.00%
Annual Report FY 10-K 2018-03-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-09-30 0.00% -86.01% -87.33%
Quarterly Report Q1 8-K 2024-06-30 0.00% -17.87% -27.50%
Quarterly Report Q4 8-K 2024-03-31 0.00% -26.73% -25.76%
Quarterly Report Q3 8-K 2023-12-31 0.00% 18.68% -17.03%
Quarterly Report Q2 8-K 2023-09-30 0.00% -22.40% -17.32%
Quarterly Report Q1 8-K 2023-06-30 0.00% -83.13% -83.15%
Quarterly Report Q4 8-K 2023-03-31 0.00% -25.99% -36.07%
Quarterly Report Q3 8-K 2022-12-31 0.00% -52.78% -6.38%
Quarterly Report Q2 8-K 2022-09-30 0.00% -27.12% -31.78%
Quarterly Report Q1 8-K 2022-06-30 0.00% -32.50% -35.10%
Quarterly Report Q4 8-K 2022-03-31 0.00% -67.52% -63.45%
Quarterly Report Q3 8-K 2021-12-31 0.00% -30.24% -30.80%
Quarterly Report Q2 8-K 2021-09-30 0.00% -81.36% -79.51%
Quarterly Report Q1 8-K 2021-06-30 0.00% -14.09% -12.41%
Quarterly Report Q4 8-K 2021-03-31 0.00% -37.02% -41.18%
Quarterly Report Q3 8-K 2020-12-31 0.00% -181.30% -186.57%
Quarterly Report Q2 8-K 2020-09-30 0.00% -16619.23% -4896.70%
Quarterly Report Q1 8-K 2020-06-30 0.00% -14614.58% -28690.80%
Quarterly Report Q4 8-K 2020-03-31 0.00% -4566788.89% -4551677.78%
Quarterly Report Q3 8-K 2019-12-31 0.00% -27.65% -24.27%
Quarterly Report Q2 8-K 2019-09-30 0.00% 101.97% 93.27%
Quarterly Report Q1 8-K 2019-06-30 0.00% 104.18% 97.89%
Quarterly Report Q4 8-K 2019-03-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-09-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-06-30 0.00% 0.00% 0.00%